Infectious diseases

Clinical Articles iconClinical Articles

As the COVID-19 curve starts to flatten in Australia and New Zealand, people are rightly wondering how we will roll back current lockdown policies. Australia’s federal health minister Greg Hunt says Australia is looking to South Korea, Japan and Singapore to inform our exit strategy. New Zealand is relaxing some measures from next week.

Expert/s: Toby Phillips
Clinical Articles iconClinical Articles

It is the world-wide experience that children appear to be at low risk of experiencing symptomatic COVID-19. Because of the low numbers, there are still a number of unanswered questions with regard to the transmission and expression of the disease in this population. Many studies are currently underway, but Professor Crawford outlines the current understanding about COVID-19 in children:

Clinical Articles iconClinical Articles

While there is little robust clinical evidence to guide the most appropriate choice and use of PPE in general practice, particularly in relation to COVID-19, knowledge about the nature of this virus can help direct efforts to prevent its spread.

Clinical Articles iconClinical Articles

There appears to be a myriad of potential treatments for our current health threat – COVID19. But just how real are these options? And which if any of these are likely to make it into our treatment regimens? A review just published online in JAMA gives us a neat summary of where we are up to in terms of treatment.

Clinical Articles iconClinical Articles

Sudden loss of smell could be a sign of COVID-19, say ENT specialists from around the world, even in the absence of other symptoms. The experts from the UK, the US and Australia are calling for anosmia to be added to the list of possible symptoms to be asked about when screening for potentially having the virus.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.